Tag: Boehringer Ingelheim
University of Sydney spinout bags $273m for psychiatric drug dev’t
Kinoxis Therapeutics, a University of Sydney spinoff, announced a partnership with German pharmaceutical company Boehringer Ingelheim to develop precision therapies that target oxytocin aimed at enhancing the quality of life for people with psychiatric disorders.
Global pharma giants join forces with Aussie research institutions to develop new cancer treatments
Two global pharmaceutical firms have teamed up with Australian research institutions to develop new treatments and drugs to fight cancer.
German pharma giant Boehringer Ingelheim...
Featured Article
Smarter energy decisions: GridBeyond unveils AI-powered Bid Optimiser in Australia
As Australia’s energy transition accelerates, businesses participating in the National Electricity Market (NEM) are facing growing challenges in managing their energy assets efficiently.
